Page 136 - ITU KALEIDOSCOPE, ATLANTA 2019
P. 136

2019 ITU Kaleidoscope Academic Conference




           machine-learning methods to predict patient-level healthcare   2.4.2   Socioeconomic status
           costs following renal transplantation.
                                                              We  included  each  patient’s  membership  of  one  of  14
                   2.  MATERIAL AND VARIABLES                 regionally  based  Local  Health  Integration  Networks
                                                              (LHINs),  which  govern  and  coordinate  health  and  social
           2.1    Patient population                          services in Ontario, Canada [18].

           We  used  all  cases  of  kidney-only  transplantation  from  a   2.4.3   Comorbidities
           deceased  donor  performed  in  Ontario,  Canada  between
           March 31, 2002 and April 1, 2013. Recipients aged over 60   We  considered  each  patient’s  status  of  the  11  Collapsed
           were followed until death or to April 1, 2016 (N=1425). We   Aggregated  Disease  Groups  (CADG)  as  defined  in  Johns
           excluded the small number of patients who died within one   Hopkins’ Adjusted Clinical Group (ACG® [19]) case-mix
           year after transplant (N=70, 4.9%) in order to have our final   system,  a  well-validated  method  of  categorizing
           model  generalize  to  the  more  homogeneous  group  of   comorbidities  [20].  We  excluded  CADG  12  (pregnancy)
           transplant recipients who survived for at least a year. We   since no patients in our cohort were pregnant at the time of
           further excluded patients with missing data on healthcare use   transplantation.   CADGs   were   established   using
           (N=27, 1.9%), most of whom were transplanted during the   administrative  records,  including  diagnostic  codes  in  the
           earliest  year  of  our  study  period,  2002  (N=19  of  the  27   format  of  the  International  Statistical  Classification  of
           patients  with  unknown  healthcare  use).  These  exclusions   Disease and Related Health Problems, 10  version, Canada
                                                                                                th
           resulted in a total of 1328 transplant recipients in the cohort.   (ICD-10-CA), from the Discharge Abstract Database (DAD),
                                                              a database that includes acute care inpatient hospitalization;
           2.2    Data sources                                physician billing codes from the Ontario Health Insurance
                                                              Plan  (OHIP);  and  records  from  the  National  Ambulatory
           We used a multicenter, population-based dataset derived by   Care Reporting System (NACRS). ICD-10-CA codes were
           the  Institute  for  Clinical  Evaluative  Sciences  (ICES)  in   first assigned to one of the 32 Aggregated Diagnosis Groups
           Toronto, Ontario, Canada. Person-level records submitted by   (ADG)  based  on  five  clinical  dimensions,  including  the
           all (six) transplantation centers in Ontario to the Canadian   duration  of  the  condition,  severity,  diagnostic  certainty,
           Organ Replacement Registry (CORR), a national database   etiology and involvement of special care. ADGs were then
           that tracks end-stage organ failure patients, were linked to   collapsed into 12 CADGs based on the likelihood that the
           various  health  service  utilization  and  administrative   condition  would  persist  or  recur,  severity  and  the  type  of
           databases using a validated unique patient identifier [14].   healthcare services required [19].

           2.3    Outcome                                     2.4.4   Clinical characteristics

           We focused on total healthcare costs of transplant recipients   We included sensitization indicated by level of peak panel
           during the first year after transplantation. In Ontario, Canada,   reactive antibodies (PRA) of 0% (not sensitized) or > 0%
           renal transplantation is covered for all residents by universal   (sensitized), primary cause of ESRD (glomerulonephritis /
           public health insurance. Costs were calculated at the patient   autoimmune,  diabetes,  renal  vascular,  cystic  /  genetic,  or
           level  across  healthcare  sectors  using  a  validated,  micro-  others), and blood type (O, A, B, or AB).
           costing,  algorithm  [15].  We  reported  costs  in  Canadian
           Dollars  (CAD)  that  were  adjusted  to  2019  (April)  values   2.4.5   Transplant information
           using the monthly Consumer Price Index [16], where $1.00
           CAD = $0.75 USD [17].                              We  considered  dialysis  vintage  (pre-emptive  transplant  or
                                                              transplantation  without  initiating  dialysis,  or  transplant
           2.4    Predictors                                  following dialysis duration of <6 months, 6-12 months or >
                                                              12 months) and graft number (first graft or re-graft).
           We  considered  a  similar  set  of  patient-level  predictors  as
           those examined by Patzer et al. [8] and Tan et al. [9] in their   2.4.6   Pre-transplant healthcare use
           respective iChoose Kidney models. Five categories of patient
           attributes  were  collected  at  transplantation  that  we  have   For each patient, we calculated the total healthcare costs for
           listed below.                                      during a 6-month workup period before transplant and for
                                                              the  12-month  period before  the  start  of  workup (i.e., pre-
           2.4.1   Demographics                               workup). Costs were measured in 2019 (April) CAD.

           We included patient sex (female or male), age (61-70, 71-80,   There  were  missing  values  found  in  our  dataset  for  race
           or 81+) and race (Caucasian, African American, Asian or   (N=98,  7.4%),  sensitization  (N=237,  17.8%)  and  primary
           Pacific Islanders, or others).                     cause of ESRD (N=296, 22.3%). In our primary regression
                                                              analysis, we imputed Caucasian for those with missing race,
                                                              not  sensitized  (peak  PRA  =  0%)  for  those  with  missing
                                                              sensitization,  and  glomerulonephritis  /  autoimmune  for




                                                          – 116 –
   131   132   133   134   135   136   137   138   139   140   141